Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic adverse events before and after glucocorticoid pulse therapy in rheumatoid arthritis
2009-017051-10Phase 4Completed
- Sponsor
- University Medical Center Utrecht
- Start
- May 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexamethasone in rheumatoid arthritis (RA), sponsored by University Medical Center Utrecht. Primary endpoint: Metabolic disturbances after dexamethasone pulse therapy. Started May 2010; status: completed.
02
Drugs
dexamethasone
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2009-017051-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017051-10.